Related Experiment Video
Updated: Jan 3, 2026

Assessing Lysosomal Alkalinization in the Intestine of Live Caenorhabditis elegans
Published on: April 13, 2018
Can autophagy protect against neurodegeneration caused by aggregate-prone proteins?
Brinda Ravikumar1, David C Rubinsztein
1Department of Medical Genetics, Cambridge Institute for Medical Research, Wellcome/MRC Building, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 2XY, UK.
Abstract:
Protein conformation disorders or proteinopathies are a growing family of human diseases that are characterized by the accumulation of proteins in intracellular aggregates (also known as inclusions) in specific tissues/organs. The role of aggregates in these diseases has been a subject of vigorous debate. However, irrespective of the nature(s) of the toxic species, it is desirable for cells to be able to control the levels of these toxic proteins and restrict their accumulation. Here we discuss how the autophagy-lysosome pathway may regulate protein clearance in some of the protein conformation disorders and why this pathway may represent a possible therapeutic target in such conditions.
Insights
Protein conformation disorders involve toxic protein buildup. The autophagy-lysosome pathway may clear these proteins, offering a potential therapeutic target for proteinopathies.
Area of Science:
- Neuroscience
- Cell Biology
- Genetics
Background:
- Protein conformation disorders, or proteinopathies, are a class of diseases characterized by the accumulation of misfolded proteins into intracellular aggregates.
- The precise role of these protein aggregates in disease pathogenesis remains under investigation, though controlling toxic protein levels is crucial.
Purpose of the Study:
- To explore the role of the autophagy-lysosome pathway in clearing toxic proteins implicated in protein conformation disorders.
- To evaluate the potential of the autophagy-lysosome pathway as a therapeutic target for these diseases.
Main Methods:
- Literature review and discussion of existing research on proteinopathies and cellular clearance mechanisms.
- Analysis of the autophagy-lysosome pathway's involvement in managing intracellular protein aggregation.
Main Results:
- The autophagy-lysosome pathway is a key cellular mechanism for degrading aggregated proteins.
- Evidence suggests this pathway's dysregulation in certain protein conformation disorders.
Conclusions:
- Targeting the autophagy-lysosome pathway presents a promising therapeutic strategy for managing protein accumulation in proteinopathies.
- Enhancing cellular protein clearance via this pathway could mitigate disease progression.
Related Concept Videos
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...

